The End­points Slack in­ter­view: Celli­no CEO Nabi­ha Sak­layen on cell ther­a­py's fu­ture, Elon Musk and time trav­el

Nabi­ha Sak­layen found­ed Celli­no Biotech just as she was fin­ish­ing her PhD in physics at Har­vard in 2017, while she was still in her 20s.

The start­up is try­ing to cre­ate au­to­mat­ed ways to pro­duce cell ther­a­pies and raised an $80 mil­lion Se­ries A round in 2022 to get to work. End­points News caught up with Sak­layen on how that ef­fort is go­ing, as well as her thoughts on Elon Musk, mis­sion con­trol at Celli­no, and even time trav­el.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER